From: Qualifying and quantifying the precision medicine rhetoric
Initial search terms | Precision or personalized medicine (initiative or study) |
Precision medicine and personalized medicine: tailoring of medical treatment to the individual characteristics of each patient … the ability to classify individuals into subpopulations that differ in their susceptibility to a particular disease, in the biology and/or prognosis of those diseases they may develop, or in their response to a specific treatment … [2] | |
Personalized medicine: improvements in the stratification and timing of health care by utilizing biological information and biomarkers on the level of molecular disease pathways, genetics, proteomics, and metabolomics [29] | |
Secondary search terms | Precision medicine (initiative) [country] |
Terms discovered through literature that often relate to or are used in place of precision medicine | Genomic medicine: clinical care based on genomic information [30] |
Individualized medicine: medicine that is particularized to a human being [31] | |
Evidence-based medicine: conscientious, explicit, and judicious use of current best evidence in making decisions about the care of individual patients [32] | |
Stratified medicine: approach of proactively testing and selecting populations for specific treatments [33] | |
Big data: high-volume, high-velocity and/or high-variety information assets that enable enhanced insight, decision making, and process automation [34] | |
Translational medicine: an interdisciplinary branch of the biomedical field supported by three main pillars: benchside, bedside, and the community; the goal is to combine disciplines, resources, expertise, and techniques within these pillars to promote enhancements in prevention, diagnosis, and therapies [35] | |
P4 medicine: a systems approach to medicine that includes predictive, personalized, preventive, and participatory aspects; a revolution that is fueled by an appreciation for medicine as an information science, a holistic approach to studying the complexities of disease, emerging technologies that allow us to explore new dimensions of patient data space, and powerful new analytic technologies [36] |